Page last updated: 2024-10-27

fluorouracil and Angiomatosis Oculoorbital-Thalamic Syndrome

fluorouracil has been researched along with Angiomatosis Oculoorbital-Thalamic Syndrome in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agarwal, HC1
Sandramouli, S1
Sihota, R1
Sood, NN1

Other Studies

1 other study available for fluorouracil and Angiomatosis Oculoorbital-Thalamic Syndrome

ArticleYear
Sturge-Weber syndrome: management of glaucoma with combined trabeculotomy-trabeculectomy.
    Ophthalmic surgery, 1993, Volume: 24, Issue:6

    Topics: Child; Child, Preschool; Female; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Infant; Infant,

1993